XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument 9HJ SE0018040784 CINIS FERTILIZER AB EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument 9HJ SE0018040784 CINIS FERTILIZER AB EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument PGO0 SE0023261532 PROSTATYPE GENOMICS AB EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument PGO0 SE0023261532 PROSTATYPE GENOMICS AB EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument 76D FR0010844464 MEDESIS PHARMA IL EO 2,- EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument 76D FR0010844464 MEDESIS PHARMA IL EO 2,- EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument 9H0 FI4000233317 ENERSIZE OYJ EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument 9H0 FI4000233317 ENERSIZE OYJ EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument E2Z ES0157097017 ALMIRALL S.A. EO -,12 EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument E2Z ES0157097017 ALMIRALL S.A. EO -,12 EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument Z0Y US46982L1089 JACOBS SOLUTIONS INC. DL1 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument Z0Y US46982L1089 JACOBS SOLUTIONS INC. DL1 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument DEVL SG1L01001701 DBS GRP HLDGS SD 1 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument DEVL SG1L01001701 DBS GRP HLDGS SD 1 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument AF8 NO0003078107 AF GRUPPEN ASA A NK 0,05 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument AF8 NO0003078107 AF GRUPPEN ASA A NK 0,05 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument MX7A HK0200030994 MELCO INTL SUBDIV. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument MX7A HK0200030994 MELCO INTL SUBDIV. EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Die USA haben fertig! 5 Aktien für den China-Boom

Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!

Hier klicken

Zeit	Aktuelle Nachrichten
12:29	Minutes of the Annual General Meeting in AF Gruppen ASA
08:29	AF Gruppen Q1 Profit Before Tax Surges With Strong Order Backlog
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
08.05.	AF Gruppen ASA: Invitation to presentation of the Q1 2025 results
07.05.	AF Gruppen ASA: Building apartments in Drammen

Zeit

Aktuelle Nachrichten

12:29

Minutes of the Annual General Meeting in AF Gruppen ASA

08:29

AF Gruppen Q1 Profit Before Tax Surges With Strong Order Backlog

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

08.05.

AF Gruppen ASA: Invitation to presentation of the Q1 2025 results

07.05.

AF Gruppen ASA: Building apartments in Drammen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
Mo	Almirall, S.A. reports Q1 results
Mo	Almirall Q1 2025 slides: Biologics fuel 15% sales growth despite revenue miss
Mo	Almirall Q1 Results Climb; Sees Sales Growth In FY25
Mo	ALMIRALL, S.A.: Resolutions approved by the Board of Directors

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

Almirall, S.A. reports Q1 results

Almirall Q1 2025 slides: Biologics fuel 15% sales growth despite revenue miss

Almirall Q1 Results Climb; Sees Sales Growth In FY25

ALMIRALL, S.A.: Resolutions approved by the Board of Directors

Zeit	Aktuelle Nachrichten
11:00	Cinis Fertilizer AB: Bulletin from the Extraordinary General Meeting in Cinis Fertilizer AB (publ)	Cinis Fertilizer AB (publ), reg. no 559154-0322 (the "Company"), has today, on 15 May 2025, held an Extraordinary General Meeting. The Extraordinary General Meeting was held by physical presence of... ► Artikel lesen
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
08.05.	Cinis Fertilizer AB: Interim report for the period January 1 - March 31, 2025	Important steps forward in the tuning of the plant In the first quarter of 2025, Cinis has taken important steps forward in the work with improvement measures and process tuning to reach a higher production... ► Artikel lesen
07.05.	CINIS FERTILIZER AB: Cinis Fertilizer announces approval of written procedure
02.05.	Cinis Fertilizer AB: Bulletin from the Extraordinary General Meeting in Cinis Fertilizer AB (publ)	Cinis Fertilizer AB, reg. no 559154-0322, (the "Company"), has today, on 2 May 2025, held an Extraordinary General Meeting. The Extraordinary General Meeting was held by physical presence of shareholders... ► Artikel lesen

Zeit

Aktuelle Nachrichten

11:00

Cinis Fertilizer AB: Bulletin from the Extraordinary General Meeting in Cinis Fertilizer AB (publ)

Cinis Fertilizer AB (publ), reg. no 559154-0322 (the "Company"), has today, on 15 May 2025, held an Extraordinary General Meeting. The Extraordinary General Meeting was held by physical presence of...
► Artikel lesen

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

08.05.

Cinis Fertilizer AB: Interim report for the period January 1 - March 31, 2025

Important steps forward in the tuning of the plant In the first quarter of 2025, Cinis has taken important steps forward in the work with improvement measures and process tuning to reach a higher production...
► Artikel lesen

07.05.

CINIS FERTILIZER AB: Cinis Fertilizer announces approval of written procedure

02.05.

Cinis Fertilizer AB: Bulletin from the Extraordinary General Meeting in Cinis Fertilizer AB (publ)

Cinis Fertilizer AB, reg. no 559154-0322, (the "Company"), has today, on 2 May 2025, held an Extraordinary General Meeting. The Extraordinary General Meeting was held by physical presence of shareholders...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
08.05.	DBS tweaks 2025 guidance as Q1 profit beats expectations
08.05.	DBS: Structural Gains From Wealth Versus PB-Only Business
08.05.	DBS' net profit fell 2% to S$2.9b in Q1 2025 on higher tax expenses.
08.05.	DBS Forecasts Lower Profit From Global Minimum Tax

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

08.05.

DBS tweaks 2025 guidance as Q1 profit beats expectations

08.05.

DBS: Structural Gains From Wealth Versus PB-Only Business

08.05.

DBS' net profit fell 2% to S$2.9b in Q1 2025 on higher tax expenses.

08.05.

DBS Forecasts Lower Profit From Global Minimum Tax

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
Fr	Enersize Oyj: Bulletin From The Extraordinary General Meeting Of Enersize Oyj	Today, on 9 May 2025, an extraordinary general meeting of Enersize Oyj ("Enersize" or the "Company") was held. At the extraordinary general meeting, 400.813.688 shares (10.37%) and votes were represented.... ► Artikel lesen
05.05.	Enersize Oyj: A New Beginning - With Respect for Our Legacy and a Clear Focus on the Future	Dear shareholders, customers, and partners, my name is Fredrik Arrigucci, and I have recently assumed the role of Chief Executive Officer at Enersize. It is with great humility and strong confidence... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

Enersize Oyj: Bulletin From The Extraordinary General Meeting Of Enersize Oyj

Today, on 9 May 2025, an extraordinary general meeting of Enersize Oyj ("Enersize" or the "Company") was held. At the extraordinary general meeting, 400.813.688 shares (10.37%) and votes were represented....
► Artikel lesen

05.05.

Enersize Oyj: A New Beginning - With Respect for Our Legacy and a Clear Focus on the Future

Dear shareholders, customers, and partners, my name is Fredrik Arrigucci, and I have recently assumed the role of Chief Executive Officer at Enersize. It is with great humility and strong confidence...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
Mi	Jacobs to lead Marinus Link interconnector project
Mi	Jacobs übernimmt Leitung des Marinus Link-Verbindungsprojekts
Di	5 Analysts Have This To Say About Jacobs Solutions
07.05.	RBC lifts Jacobs Engineering stock target to $154, keeps Outperform

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

Jacobs to lead Marinus Link interconnector project

Jacobs übernimmt Leitung des Marinus Link-Verbindungsprojekts

5 Analysts Have This To Say About Jacobs Solutions

07.05.

RBC lifts Jacobs Engineering stock target to $154, keeps Outperform

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025		Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
11.03.	XFRA 76D: AUSSETZUNG/SUSPENSION		DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMEDESIS PHARMA SA... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

11.03.

XFRA 76D: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMEDESIS PHARMA SA...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:08	MELCO INT'L DEV (00200): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
06:04	MELCO INT'L DEV (00200): PASSING AWAY OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
08.05.	MELCO INT'L DEV (00200): ANNOUNCEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 31 MARCH 2025 BY A LISTED SUBSIDIARY - MELCO RESORTS ...
08.05.	MELCO INT'L DEV (00200): OVERSEAS REGULATORY ANNOUNCEMENT

Zeit

Aktuelle Nachrichten

06:08

MELCO INT'L DEV (00200): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

06:04

MELCO INT'L DEV (00200): PASSING AWAY OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

08.05.

MELCO INT'L DEV (00200): ANNOUNCEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 31 MARCH 2025 BY A LISTED SUBSIDIARY - MELCO RESORTS ...

08.05.

MELCO INT'L DEV (00200): OVERSEAS REGULATORY ANNOUNCEMENT

Zeit	Aktuelle Nachrichten
08:30	Prostatype Genomics AB: Prostatype Genomics updates on commercial progress in the U.S.	Prostatype Genomics announces that the company's commercial activities in the U.S. continue to develop in a positive way. The number of selected American urologists at urology clinics/hospitals who... ► Artikel lesen
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
15.04.	Prostatype Genomics AB: Prostatype Genomics AB resolves on a rights issue of units to fund completion of US validation study and Medicare approval process as well as ongoing commercialization activities in the US and Europe	NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA... ► Artikel lesen
10.04.	Prostatype Genomics AB: Prostatype Genomics newsletter highlights positive U.S. study results and increasing clinical use in Italy	This newsletter highlights two significant achievements: positive preliminary results in the U.S. study with Prostatype® conducted with leading U.S. institutions, and that the clinical use of Prostatype®... ► Artikel lesen
14.02.	Prostatype Genomics AB receives observation status	On February 13, 2025, Prostatype Genomics AB (the "Company") disclosed its annual financial statement release for 2024 with information on the Company's financial situation. The rules of Nasdaq... ► Artikel lesen

Zeit

Aktuelle Nachrichten

08:30

Prostatype Genomics AB: Prostatype Genomics updates on commercial progress in the U.S.

Prostatype Genomics announces that the company's commercial activities in the U.S. continue to develop in a positive way. The number of selected American urologists at urology clinics/hospitals who...
► Artikel lesen

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

15.04.

Prostatype Genomics AB: Prostatype Genomics AB resolves on a rights issue of units to fund completion of US validation study and Medicare approval process as well as ongoing commercialization activities in the US and Europe

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA...
► Artikel lesen

10.04.

Prostatype Genomics AB: Prostatype Genomics newsletter highlights positive U.S. study results and increasing clinical use in Italy

This newsletter highlights two significant achievements: positive preliminary results in the U.S. study with Prostatype® conducted with leading U.S. institutions, and that the clinical use of Prostatype®...
► Artikel lesen

14.02.

Prostatype Genomics AB receives observation status

On February 13, 2025, Prostatype Genomics AB (the "Company") disclosed its annual financial statement release for 2024 with information on the Company's financial situation. The rules of Nasdaq...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025	Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen
Mi	R&S Group Holding AG: Results of Annual Shareholders Meeting of R&S Group Holding AG	R&S Group Holding AG / Key word(s): AGMEGM Results of Annual Shareholders Meeting of R&S Group Holding AG 14.05.2025 / 16:15 CET/CEST News release Results of Annual Shareholders... ► Artikel lesen
07.05.	Adhoc: R&S Group Holding AG: R&S Group acknowledges the full exit of its shareholder CGS	R&S Group Holding AG / Key word(s): Miscellaneous R&S Group acknowledges the full exit of its shareholder CGS 07-May-2025 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to... ► Artikel lesen
02.05.	XFRA NEW INSTRUMENTS AVAILABLE ON 02.05.2025	The following instruments on XETRA do have their first trading 02.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.05.2025 Aktien 1 CH0432492467 Alcon AG 2U3 2 CH0110240600... ► Artikel lesen
15.04.	Adhoc: R&S Group Holding AG: R&S Group publishes annual report 2024 with record profitability, solid cash conversion and confirmed growth path	R&S Group Holding AG / Key word(s): Annual Results R&S Group publishes annual report 2024 with record profitability, solid cash conversion and confirmed growth path 15-Apr-2025 / 06:30... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

R&S Group Holding AG: Results of Annual Shareholders Meeting of R&S Group Holding AG

R&S Group Holding AG / Key word(s): AGMEGM Results of Annual Shareholders Meeting of R&S Group Holding AG 14.05.2025 / 16:15 CET/CEST News release Results of Annual Shareholders...
► Artikel lesen

07.05.

Adhoc: R&S Group Holding AG: R&S Group acknowledges the full exit of its shareholder CGS

R&S Group Holding AG / Key word(s): Miscellaneous R&S Group acknowledges the full exit of its shareholder CGS 07-May-2025 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to...
► Artikel lesen

02.05.

XFRA NEW INSTRUMENTS AVAILABLE ON 02.05.2025

The following instruments on XETRA do have their first trading 02.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.05.2025 Aktien 1 CH0432492467 Alcon AG 2U3 2 CH0110240600...
► Artikel lesen

15.04.

Adhoc: R&S Group Holding AG: R&S Group publishes annual report 2024 with record profitability, solid cash conversion and confirmed growth path

R&S Group Holding AG / Key word(s): Annual Results R&S Group publishes annual report 2024 with record profitability, solid cash conversion and confirmed growth path 15-Apr-2025 / 06:30...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
AF GRUPPEN ASA	13,600	+0,44 %
ALMIRALL SA	9,940	-0,50 %
CINIS FERTILIZER AB	0,160	+2,17 %
DBS GROUP HOLDINGS LTD	31,160	+0,29 %
ENERSIZE OYJ	0,000	0,00 %
JACOBS SOLUTIONS INC	114,00	+0,88 %
MEDESIS PHARMA SA	0,290	0,00 %
MELCO INTERNATIONAL DEVELOPMENT LTD	0,466	+2,64 %
PROSTATYPE GENOMICS AB	0,138	-22,47 %
R&S GROUP HOLDING AG	23,000	0,00 %

Unternehmen / Aktien

Kurs

AF GRUPPEN ASA

13,600

+0,44 %

ALMIRALL SA

9,940

-0,50 %

CINIS FERTILIZER AB

0,160

+2,17 %

DBS GROUP HOLDINGS LTD